Key Takeaways:
- Who is involved? Andermatt Nederland bv and Entocare C.V.
- What is the agreement for? Andermatt will acquire Entocare’s beneficial insect activities starting January 1, 2025.
- Why is this important? Strengthens Andermatt’s position in biological crop protection solutions.
- Who benefits? Farmers and growers seeking sustainable pest management options.
- What’s next? Integration of Entocare’s expertise into Andermatt to broaden biocontrol offerings.
Andermatt Nederland Acquires Entocare’s Beneficial Insect Activities
Andermatt Nederland bv has announced the acquisition of Entocare C.V.’s activities in beneficial insects for biological pest control, effective January 1, 2025. This strategic move strengthens Andermatt’s role as a leading provider of biological crop protection solutions and expands its product portfolio with innovative technologies and services.
Simon Fleischli, CEO of Andermatt Nederland, expressed enthusiasm about the acquisition. “We are delighted to welcome Entocare to the Andermatt Group. This acquisition is a significant step in our mission to make agriculture more sustainable and environmentally friendly. Together, we will continue to develop new solutions that meet the needs of our customers.”
Entocare’s Expertise in Biocontrol
Entocare, based in Wageningen, specializes in developing and supplying beneficial insects for biological pest management. With a strong focus on research and development, Entocare provides tailored and effective solutions for various plant applications.
Known for its expertise in beneficial insect production, Entocare’s integration into Andermatt will enable a broader range of sustainable solutions aimed at increasing yields and protecting crops.
Maedeli Hennekam, CEO and owner of Entocare, highlighted the shared vision. “At Entocare, we have always been dedicated to sustainable crop protection through innovative biological solutions. By joining the Andermatt Group, we can expand our impact and continue our mission to protect crops and the environment.”
